AU2801697A - Secreted proteins - Google Patents

Secreted proteins

Info

Publication number
AU2801697A
AU2801697A AU28016/97A AU2801697A AU2801697A AU 2801697 A AU2801697 A AU 2801697A AU 28016/97 A AU28016/97 A AU 28016/97A AU 2801697 A AU2801697 A AU 2801697A AU 2801697 A AU2801697 A AU 2801697A
Authority
AU
Australia
Prior art keywords
secreted proteins
secreted
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28016/97A
Other languages
English (en)
Inventor
Kenneth Jacobs
Edward R. Lavallie
John M Mccoy
David Merberg
Lisa A. Racie
Vikki Spaulding
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Publication of AU2801697A publication Critical patent/AU2801697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU28016/97A 1996-04-18 1997-04-14 Secreted proteins Abandoned AU2801697A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63432596A 1996-04-18 1996-04-18
US08634325 1996-04-18
PCT/US1997/006139 WO1997039123A2 (en) 1996-04-18 1997-04-14 Secreted proteins

Publications (1)

Publication Number Publication Date
AU2801697A true AU2801697A (en) 1997-11-07

Family

ID=24543331

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28016/97A Abandoned AU2801697A (en) 1996-04-18 1997-04-14 Secreted proteins

Country Status (4)

Country Link
EP (1) EP0912731A2 (de)
JP (1) JP2001509004A (de)
AU (1) AU2801697A (de)
WO (1) WO1997039123A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6280739B1 (en) * 1996-04-18 2001-08-28 Genetics Institute, Inc. Method of inhibiting angiogenesis using secreted proteins
WO1999000408A2 (en) * 1997-05-13 1999-01-07 Incyte Pharmaceuticals, Inc. Human transmembrane protein from the transmembrane 4 superfamily
US5872234A (en) * 1997-06-27 1999-02-16 Incyte Pharmaceuticals, Inc. Human extracellular matrix proteins
US6846647B1 (en) * 1998-04-28 2005-01-25 Ono Pharmaceutical Co., Ltd. Polypeptides suppressing smooth muscle cell proliferation, the encoding cDNA, and related methods
EP1141267A4 (de) * 1998-12-23 2003-01-15 Inst Genetics Llc Ausgeschiedene proteine
AU2001266765A1 (en) * 2000-06-06 2001-12-17 Incyte Genomics, Inc. Extracellular messengers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550110A (en) * 1992-04-22 1996-08-27 Warner-Lambert Company Endothelin Antagonists II

Also Published As

Publication number Publication date
JP2001509004A (ja) 2001-07-10
EP0912731A2 (de) 1999-05-06
WO1997039123A2 (en) 1997-10-23
WO1997039123A3 (en) 1998-02-26

Similar Documents

Publication Publication Date Title
AU4922497A (en) Interleukin-18-receptor proteins
AU6552198A (en) 28 human secreted proteins
AU2306499A (en) 110 human secreted proteins
AU6952998A (en) 20 human secreted proteins
AU5796298A (en) Secreted human proteins
AU6721696A (en) Cd44-like protein
AU8066998A (en) 86 human secreted proteins
AU9130498A (en) 50 human secreted proteins
AU8404598A (en) 64 human secreted proteins
AU1273499A (en) 148 human secreted proteins
AU3616797A (en) Phosphate starvation-inducible proteins
AU8921598A (en) 29 human secreted proteins
AU2181197A (en) Connecting part
AU8176798A (en) Secreted proteins
AU2801697A (en) Secreted proteins
AU6000698A (en) Proteins
AU6275098A (en) Novel h-rev 107-like protein
AU4809497A (en) Secreted proteins
AU2390800A (en) Secreted proteins
EP1037898A4 (de) Sekrietierte proteine
AU2734497A (en) Secreted proteins
AU2732997A (en) Secreted proteins
AU4505497A (en) Snrnp sm proteins
AU6522199A (en) Secreted protein zsig49
AU9115898A (en) Secreted proteins